Financhill
Back

Astellas Pharma 10K Form

Buy
51

ALPMY
Astellas Pharma

Last Price:
11.68
Seasonality Move:
0.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALPMY News And Ratings

See the #1 stock for the next 7 days that we like better than ALPMY

ALPMY Financial Statistics

Sales & Book Value

Annual Sales: $11.11B
Cash Flow: $366.7M
Price / Cash Flow: 0
Annual Sales: $5.88
Price / Book: 1.98

Profitability

EPS (TTM): 0.05830
Net Income (TTM): $105.19M
Gross Margin: $9.09B
Return on Equity: 0.97%
Return on Assets: 0.47%

Astellas Pharma Earnings Forecast

Key Astellas Pharma Financial Ratios

  • The Gross Profit Margin over the past 21 years for ALPMY is 81.76%.
  • The Selling, General & Administrative Expenses for ALPMY have been equal to 46.15% of Gross Profit Margin.
  • The Research & Development expenses have been 18.34% of Revenue.
  • The Interest Expense is 70.43% of Operating Income.
  • The Net Earning history of ALPMY is 1.06% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 10 years.

Astellas Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ALPMY
Website: astellas.com

Debt

Debt-to-Equity Ratio: 0.58
Current Ratio: 0.93
Quick Ratio: 0.71

Price-to-Earnings

Trailing P/E Ratio: 177.98
Forward P/E Ratio: 0

ALPMY Technical Analysis vs Fundamental Analysis

Buy
51
Astellas Pharma (ALPMY) is a Buy

Is Astellas Pharma a Buy or a Sell?

  • Astellas Pharma stock is rated a Buy
    The current Astellas Pharma [ALPMY] share price is $11.68. The Score for ALPMY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.